<div id="readability-page-1"><p>Plexus Corp. (NASDAQ:PLXS - Get Free Report) CFO Patrick John Jermain sold 3,587 shares of the firm's stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $204.09, for a total transaction of $732,070.83. Following the completion of the transaction, the chief financial officer directly owned 16,882 shares of the company's stock, valued at approximately $3,445,447.38. This represents a 17.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.</p><ul><li>This mid-cap tech stock just jumped 30%...and is still cheap</li></ul><p>Patrick John Jermain also recently made the following trade(s): </p><ul><li>On Tuesday, February 3rd, Patrick John Jermain sold 4,841 shares of Plexus stock. The shares were sold at an average price of $204.01, for a total transaction of $987,612.41. </li><li>On Tuesday, November 11th, Patrick John Jermain sold 2,000 shares of Plexus stock. The stock was sold at an average price of $143.53, for a total value of $287,060.00. </li></ul><h2>Plexus Stock Performance</h2><p>PLXS traded up $5.15 on Friday, reaching $206.22. 503,420 shares of the stock were exchanged, compared to its average volume of 362,753. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. The company's 50-day moving average price is $164.72 and its 200 day moving average price is $147.67. The firm has a market capitalization of $5.52 billion, a PE ratio of 32.07 and a beta of 0.81. Plexus Corp. has a fifty-two week low of $103.43 and a fifty-two week high of $208.92. </p><p>Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, January 28th. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.77 by $0.01. Plexus had a return on equity of 12.39% and a net margin of 4.28%.The firm had revenue of $1.07 billion during the quarter, compared to analysts' expectations of $1.07 billion. During the same period last year, the business posted $1.73 earnings per share. The company's revenue for the quarter was up 9.6% compared to the same quarter last year. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS.  As a group, sell-side analysts forecast that  Plexus Corp. will post 5.9 EPS for the current fiscal year. </p><h2>Institutional Trading of Plexus</h2><p>Institutional investors and hedge funds have recently made changes to their positions in the business. Salomon &amp; Ludwin LLC purchased a new position in shares of  Plexus during the 3rd quarter valued at approximately $30,000.  Covestor Ltd increased its holdings in  Plexus by 207.7% in the 4th quarter. Covestor Ltd now owns 240 shares of the technology company's stock worth $35,000 after acquiring an additional 162 shares in the last quarter.  Allworth Financial LP raised its position in  Plexus by 70.1% during the third quarter. Allworth Financial LP now owns 250 shares of the technology company's stock worth $36,000 after acquiring an additional 103 shares during the period.  Huntington National Bank lifted its holdings in  Plexus by 41.5% during the second quarter. Huntington National Bank now owns 324 shares of the technology company's stock valued at $44,000 after purchasing an additional 95 shares in the last quarter.  Finally, Johnson Financial Group Inc. purchased a new position in  Plexus during the third quarter valued at $72,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several analysts have recently commented on PLXS shares. Sidoti downgraded shares of Plexus from a &#34;buy&#34; rating to a &#34;neutral&#34; rating and set a $150.00 price objective on the stock. in a report on Friday, October 24th. Benchmark boosted their target price on shares of Plexus from $165.00 to $195.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, January 28th. Stifel Nicolaus increased their price target on Plexus from $150.00 to $200.00 and gave the stock a &#34;hold&#34; rating in a research report on Friday, January 30th. Weiss Ratings  reiterated a &#34;hold (c+)&#34; rating on shares of Plexus in a research note on Thursday, January 22nd. Finally, Williams Trading  set a $195.00 price objective on Plexus in a report on Wednesday, January 28th. Two analysts have rated the stock with a Buy rating and three have assigned  a Hold rating to the stock. Based on data from MarketBeat.com, Plexus presently has an average rating of &#34;Hold&#34; and a consensus price target of $189.20.</p><p><b>Read Our Latest Stock Report on Plexus</b></p><h2>About Plexus</h2> (Get Free Report)<p>Plexus Corp. <span>NASDAQ: PLXS<span></span></span> is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.  </p><p>Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Plexus</li><li>What a Former CIA Agent Knows About the Coming Collapse</li><li>NEW LAW: Congress Approves Setup For Digital Dollar?</li><li>Trade this between 9:30 and 10:45 am EST</li><li>Buy this stock tomorrow?</li><li>~$1.5T SpaceX IPO: Pre-IPO Opportunity</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExYUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9UExYUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Plexus Right Now?</h2><p>Before you consider Plexus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.</p><p>While Plexus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

PLXS

<p>Plexus Corp. CFO Patrick John Jermain sold 3,587 shares of the company's stock for $732,070.83 on February 4th, reducing his ownership by 17.52%. Following the sale, he holds 16,882 shares valued at approximately $3.45 million. The stock traded at $206.22, with a market cap of $5.52 billion. Analysts have mixed ratings on Plexus, with price targets ranging from $150 to $200. The company reported $1.78 EPS for the last quarter, slightly above estimates, and revenue increased by 9.6% year-over-year.</p>

Insider Selling: Plexus (NASDAQ:PLXS) CFO Sells $732,070.83 in Stock